Back

Case 1 - troponin elevation during immune checkpoint inhibitors therapy: myocarditis or not?

31 August 2026 (11:15 - 11:35)
Organised by: Logo
Congress Presentation Part of: Clinical Case Management: smarter surveillance over the course of cancer care Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Anju Nohria

New York University, New York (United States of America)

2 More presentations in this session

Presentation thumbnail
Case 2 - asymptomatic decline in global longitudinal strain during cancer therapy: what should guide our decisions
Professor A. Barac (Fairfax, US)
Slides Video
Presentation thumbnail
Clinical Case Management: smarter surveillance over the course of cancer care - discussion
Video

Access the full session

Session thumbnail
Clinical Case Management: smarter surveillance over the course of cancer care
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Session
Immune checkpoint inhibitors and the many faces of cardiac injury: from myocarditis to coronary and conduction disease
19 June 2026
thumbnail
Congress Presentation
Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-induced myocarditis and myositis.
28 August 2022
thumbnail
Congress Presentation
Fatal pembrolizumab cardiotoxicity refractory to corticosteroid therapy: A case of atrial fibrillation, atrioventricular blocks, ventricular arrhythmias, and clinically suspected myocarditis
28 August 2023
thumbnail
Congress Presentation
Checkpoint inhibitor associated myocarditis.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources